dimethyl fumarate stada
stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 240 mg - dimethyl fumarate
fulvestrant stada
stada arzneimittel ag - fulvestrantas - injekcinis tirpalas užpildytame švirkšte - 250 mg - fulvestrant
gemcitabine stada
stada arzneimittel ag - gemcitabinas - koncentratas infuziniam tirpalui - 38 mg/ml - gemcitabine
cabazitaxel stada
stada arzneimittel ag - kabazitakselis - koncentratas infuziniam tirpalui - 20 mg/ml - cabazitaxel
stadapress
stada arzneimittel ag - moksonidinas - plėvele dengtos tabletės - 0,4 mg; 0,3 mg; 0,2 mg - moxonidine
hirudoid
stada baltics, uab - chondroitino polisulfatas - gelis - 3 mg/g - organo-heparinoid
elmetacin spray
stada baltics, uab - indometacinas - odos purškalas (tirpalas) - 8 mg/ml - indometacin
venoruton
stada arzneimittel ag - o-(beta-hidroksietil)-rutozidai - šnypščiosios tabletės - 1000 mg; 20 mg/g; 500 mg - rutoside
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, žarnyno priešuždegiminiai / antiinfective agentų - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
ximluci
stada arzneimittel ag - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).